OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

Type:

Video

William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.

March 6, 2012 OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony	February 29, 2012 Ron Cohen, President and CEO, Acorda Therapeutics, Inc.	February 14, 2012 Preventing Heart Disease: Lisa Tate, CEO of WomenHeart	February 9, 2012 Podcast: David Malek, Vice President of Business Development for BioLine Rx
February 2, 2012 Jane Hollingsworth, co-founder, director and CEO of NuPathe Inc.	February 2, 2012 Tracey Mumford, The Michael J. Fox Foundation for Parkinson’s Research	January 27, 2012 2011 BIO International Convention Governors Highlight Reel	January 25, 2012 Podcast: Dr. Steve Perrin, ALS Therapy Development Institute